DK606084A - Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol - Google Patents

Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol Download PDF

Info

Publication number
DK606084A
DK606084A DK606084A DK606084A DK606084A DK 606084 A DK606084 A DK 606084A DK 606084 A DK606084 A DK 606084A DK 606084 A DK606084 A DK 606084A DK 606084 A DK606084 A DK 606084A
Authority
DK
Denmark
Prior art keywords
eestradiol
17beta
fluor
preparing
procedure
Prior art date
Application number
DK606084A
Other languages
English (en)
Other versions
DK606084D0 (da
Inventor
John Stanley Ward
Charles David Jones
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK606084D0 publication Critical patent/DK606084D0/da
Publication of DK606084A publication Critical patent/DK606084A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK606084A 1983-12-22 1984-12-18 Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol DK606084A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/564,595 US4522758A (en) 1983-12-22 1983-12-22 Method of preparing 2-fluoro-17β-estradiol

Publications (2)

Publication Number Publication Date
DK606084D0 DK606084D0 (da) 1984-12-18
DK606084A true DK606084A (da) 1985-06-23

Family

ID=24255123

Family Applications (1)

Application Number Title Priority Date Filing Date
DK606084A DK606084A (da) 1983-12-22 1984-12-18 Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol

Country Status (9)

Country Link
US (1) US4522758A (da)
EP (1) EP0147155A3 (da)
JP (1) JPS60226894A (da)
KR (1) KR860001284B1 (da)
CA (1) CA1213881A (da)
DK (1) DK606084A (da)
GR (1) GR82481B (da)
HU (1) HU192654B (da)
IL (1) IL73826A0 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668668A (en) * 1984-03-20 1987-05-26 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4676932A (en) * 1984-04-09 1987-06-30 The University Of New Mexico Synthesis of 1-haloestradiols
US20040214807A1 (en) * 1993-08-06 2004-10-28 D'amato Robert J. Estrogenic compounds as anti-mitotic agents
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6908910B2 (en) * 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
WO1997008187A1 (en) * 1995-08-30 1997-03-06 Eli Lilly And Company N-butylsulfonate esters of estrogens
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20020002294A1 (en) * 1997-09-24 2002-01-03 D' Amato Robert J. Estrogenic compounds as antiangiogenic agents
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
WO2000009101A2 (en) 1998-08-11 2000-02-24 Entremed, Inc. Use of estrogenic compounds as anti-fungal agents
US7087592B1 (en) * 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US20050192258A1 (en) * 2000-08-18 2005-09-01 Agoston Gregory E. Antiangiogenic agents
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
AU2003208913A1 (en) * 2002-01-30 2003-09-02 Entremed, Inc. Non-steroidal analogs of 2-methoxyestradiol
AU2004275693A1 (en) * 2003-05-28 2005-04-07 Entremed, Inc. Antiangiogenic agents
US20070004689A1 (en) * 2004-03-12 2007-01-04 Agoston Gregory E Antiangiogenic agents
EP1756139A4 (en) 2004-03-12 2009-07-29 Entremed Inc ANTI-ANGIOGENIC AGENTS
EP1819343A2 (en) * 2004-11-29 2007-08-22 EntreMed, Inc. A method of administering anti-angiogenic agents and a method of treating disease using same
US20070185069A1 (en) * 2005-11-14 2007-08-09 Plum Stacy M Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
US20070176403A1 (en) * 2006-02-01 2007-08-02 Dennis Calderone Air adjustable seat
US8399440B2 (en) * 2006-03-20 2013-03-19 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol
WO2008094665A1 (en) * 2007-01-31 2008-08-07 Entremed, Inc. Method of treating amyloidosis mediated diseases
RU2418000C1 (ru) * 2009-11-26 2011-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования Санкт-Петербургский государственный университет 3-МЕТОКСИ-2-ФТОР-18-ЭТИЛ-8α-ГОНА-1,3,5( 10 )-ТРИЕНЫ, ОБЛАДАЮЩИЕ ОСТЕОПРОТЕКТОРНОЙ И ГИПОХОЛЕСТЕРИНЕМИЧЕСКОЙ АКТИВНОСТЬЮ
RU2436792C1 (ru) * 2010-05-27 2011-12-20 Федеральное государственное образовательное учреждение высшего профессионального образования Санкт-Петербургский государственный университет Метиловый эфир 16,16-диметил-2-фтор-d-гомо-8альфа-эстрона, обладающий гиполипидемической и кардиопротекторной активностью
US20140296327A1 (en) 2011-10-24 2014-10-02 The Brigham And Women's Hospital, Inc. Diagnosis and treatment of mesothelioma

Also Published As

Publication number Publication date
US4522758A (en) 1985-06-11
GR82481B (en) 1985-04-18
HUT36841A (en) 1985-10-28
DK606084D0 (da) 1984-12-18
IL73826A0 (en) 1985-03-31
CA1213881A (en) 1986-11-12
KR850004500A (ko) 1985-07-15
HU192654B (en) 1987-06-29
JPS60226894A (ja) 1985-11-12
KR860001284B1 (ko) 1986-09-05
EP0147155A2 (en) 1985-07-03
EP0147155A3 (en) 1985-10-30

Similar Documents

Publication Publication Date Title
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK162647C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK225184D0 (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycinsyre
DK606084A (da) Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol
DK386784A (da) Fremgangsmaade til fremstilling af alfa-6-desoxy-tetracykliner
DK299483A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK160829C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK156085D0 (da) Fremgangsmaade til fremstilling af acetoxyazetidinoner
DK283083A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK606384A (da) Fremgangsmaade til fremstilling af krystallinske silicophosphoaluminater
DK37890A (da) Fremgangsmaade til fremstilling af 6-deoxyanthracycliner
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK399783D0 (da) Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer
DK493384D0 (da) Fremgangsmaade til fremstilling af bis-dioxopiperazin-derivater
DK9383D0 (da) Fremgangsmade til fremstilling af phosphinoxider
DK193983D0 (da) Fremgangsmade til fremstilling af substituerede phenylendiaminer
DK573184D0 (da) Fremgangsmaade til fremstilling af polyphenylenoxid
DK156061C (da) Fremgangsmaade til fremstilling af 2-alkyl-4-amino-5-aminomethylpyrimidin
DK575584D0 (da) Fremgangsmaade til fremstilling af polyphenylenoxid
DK215082A (da) Fremgangsmaade til fremstilling af 2-iminotiazolidinderivater
DK526983D0 (da) Fremgangsmade til fremstilling af sulfonerede o-phenylendiaminer

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment